About Us
About AJMC
About AJPB
Publications
AJMC
AJPB
Evidence-Based Diabetes Management
Evidence-Based Oncology
Supplements
Subscribe for FREE
AJMC TV
Interviews
Peer Exchange
Interactive
Interactive Tools
Featured Podcasts
Conferences
ACC 2013
AJMC Live Meeting - Oncology
AES2012
AHIP 2012
AHIP 2012 Fall Forum
AHIP Medicare Medicaid
AMCP Fall 2012
AMCP Spring 2013
ADA 2012
ASH 2012
CHEST 2012
Joslin Diabetes Innovation
NAMCP 2012
NAMCP Spring 2013
SCAI 2013
ATS 2013
News
Info for Authors
Information for Authors
Call for Papers
Submit / Track a Manuscript
Authorship Forms
Information for Reviewers
Resource Centers
Acute Coronary Syndrome
Biosimilars
Care Management
Diabetes
Evidence-Based Oncology
Pain
Value-Based Cardiology
Value-Based Insurance Design
Advertisement
Supplement
Archives
Issue:
Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment [CME/CPE/CNE]
Volume:
17
Number:
18 Suppl
ARTICLES
Indications for Recombinant Human Growth Hormone and Evaluation of Available Recombinant Human Growth Hormone Devices: Implications for Managed Care Organizations
Jeffrey D. Dunn, PharmD, MBA; and Nancy A. Nickman, PhD
Clinical and Humanistic Aspects of Growth Hormone Deficiency and Growth-Related Disorders
Alan D. Rogol, MD, PhD
Issues Related to Recombinant Human Growth Hormone Utilization and Optimization in a Health Plan Setting
Nancy A. Nickman, PhD; and Jeffrey D. Dunn, PharmD, MBA
AUTHOR INDEX
Participating Faculty: Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment
CE/CME QUIZ
Growth Hormone Treatment: Balancing Cost, Safety, and Outcome in a Managed Care Environment
Advertisement
Advertisement